About the Webinar

Now more than ever, clinicians must understand the non-clinical factors that influence and often determine a patient’s health outcomes. As organizations expand their approach to population health management, one thing is sure; they cannot underestimate the importance of identifying social risk and building partnerships with community agencies and social services to address this risk. Whether this means identifying high-risk patients with a stratification model based on non-clinical factors or enabling a meaningful conversation about social vulnerabilities between the doctor and patient, providers can leverage AI and Machine Learning technology, along with non-traditional, activated data to impact the health of their populations and win at Value-Based Care.

In this webinar, Mark Ganz, Former CEO at Cambia Health Solutions, Kevin F. Brennan, Senior Advisor to McKinsey and Company, and David Nace, MD, Chief Medical Officer, Innovaccer Inc., will explore how the COVID-19 pandemic has changed the non-clinical landscape of healthcare and made it necessary to address these underlying social determinants of health.

You will learn

  • How has the pandemic affected our consideration of the SDoH policies and programs of healthcare organizations?
  • What will be the financial implications that SDoH factors will have on the care delivery system in the future?
  • How do we fast-track the measurement and management of SDoH and move this into the population health management workflow?
  • What types of innovations and partnerships are vital to sustaining momentum and focus on integrating medical, social, and other community-based services to deliver the “whole person care?”
  • What are the financial considerations in addressing health equity?
  • What role do virtual care services play in measuring and managing risk? How does it impact our outcomes? Our predictive models?
  • What are the next steps to succeed, both clinically and financially in the post-pandemic environment? What changes are likely here to stay—and which will likely end in the upcoming years?

Register for the Virtual Session

Please enter valid name.
Please enter a valid email address.
Please enter valid contact number.

About the Webinar

Now more than ever, clinicians must understand the non-clinical factors that influence and often determine a patient’s health outcomes. As organizations expand their approach to population health management, one thing is sure; they cannot underestimate the importance of identifying social risk and building partnerships with community agencies and social services to address this risk. Whether this means identifying high-risk patients with a stratification model based on non-clinical factors or enabling a meaningful conversation about social vulnerabilities between the doctor and patient, providers can leverage AI and Machine Learning technology, along with non-traditional, activated data to impact the health of their populations and win at Value-Based Care.

In this webinar, Mark Ganz, Former CEO at Cambia Health Solutions, Kevin F. Brennan, Senior Advisor to McKinsey and Company, and David Nace, MD, Chief Medical Officer, Innovaccer Inc., will explore how the COVID-19 pandemic has changed the non-clinical landscape of healthcare and made it necessary to address these underlying social determinants of health.

You will learn

  • How has the pandemic affected our consideration of the SDoH policies and programs of healthcare organizations?
  • What will be the financial implications that SDoH factors will have on the care delivery system in the future?
  • How do we fast-track the measurement and management of SDoH and move this into the population health management workflow?
  • What types of innovations and partnerships are vital to sustaining momentum and focus on integrating medical, social, and other community-based services to deliver the “whole person care?”
  • What are the financial considerations in addressing health equity?
  • What role do virtual care services play in measuring and managing risk? How does it impact our outcomes? Our predictive models?
  • What are the next steps to succeed, both clinically and financially in the post-pandemic environment? What changes are likely here to stay—and which will likely end in the upcoming years?

About the Presenters

Mark Ganz
Mark Ganz
Strategic Advisory Board Member at Innovaccer & Former CEO at Cambia Health Solutions

Until his recent retirement, Mark Ganz was, for nearly 18 years, President and Chief Executive Officer of Cambia Health Solutions, a total health solutions company dedicated to transforming health care by creating a person-focused and economically sustainable system for individuals and their families. He served at Cambia and it’s predecessors for 29 years holding the position of Chief Legal Officer, Corporate Secretary, Ethics and Compliance Officer, and head of Federal Public Policy, and then President of its largest subsidiary, Regence BlueCross BlueShield of Oregon. The 104 year old company more than tripled in value on his watch, and it brought to market a number of innovative, person-focused offerings which today serve millions of Americans in the Pacific Northwest and throughout the country.

Kevin F. Brennan
Kevin F. Brennan
Senior Advisor to McKinsey & Company

Mr. Brennan serves as a Senior Advisor at McKinsey & Company and oversees a broad range of strategic and operational engagements. He also serves as a Principal with SunStone Consulting, assisting clients throughout the country with reimbursement, regulatory, revenue integrity, and strategic solutions. For 23 years, Mr. Brennan served as the Executive Vice President of Finance and Chief Financial Officer of Geisinger—a $7 billion physician-led integrated health services organization that has an array of health services providers, including hospitals, a physician group practice, a number of health insurance companies, and a medical school. Before his tenure with Geisinger Health System, he served as a CFO with other large health systems and tertiary care hospitals. Mr. Brennan served as the National Chair of the 50,000-member Healthcare Financial Management Association (HFMA) for the 2018-2019 year, following two years as an officer and three years on the Board of Directors. Mr. Brennan has been a member of HFMA since 1981 and a Fellow since 1992. He was an active member of HFMA’s Large System CFO Council, the Value Projects, the Principles and Practices Board, the Patient Transparency Task Force, and was a board member of the Metropolitan Philadelphia Chapter. Mr. Brennan holds an MBA in Healthcare Administration and a Bachelor of Science in Business Administration from LaSalle University in Philadelphia. He’s been a certified public accountant since 1979 and is a member of the Pennsylvania Institute of Certified Public Accountants.

David Nace MD
David Nace MD
Chief Medical Officer at Innovaccer, Former VP & CMO at Aetna, & Former VP at McKesson

Dr. David Nace is a physician executive with over 20 years of senior management experience in large healthcare systems, payer health plans, leading healthcare providers, and health information technology organizations. With his strong collaborative and cross-functional leadership skills, he has demonstrated excellence in business development, client relationships, communication and presentation skills, executive presence, and an ability to mentor, lead, and educate. Dr. Nace’s areas of interest include clinical integration, accountable and value-based care, patient-centered medical home, population health, and the application of technology in healthcare innovation. He is passionate about new models of care delivery, collaboration across markets and industries, disruptive innovation, and patient centered care.